Scientists aren't concerned about new coronavirus variant eluding current vaccines


The identification of a potentially more transmissible coronavirus variant, primarily in the United Kingdom, has scientists and government officials, alike, sounding the alarm. The U.K. has tightened lockdown measures, and several continental European countries are halting flights to Great Britain. There's no evidence the variant affects the severity of COVID-19 infections, but increased infectiousness would make curbing the spread even harder, which is why certain areas of the U.K. may face restrictions until there's widespread vaccine availability. But could mutations like the one in the U.K. render those vaccines ineffective?
The consensus answer is reassuring for the time being. Daniel Altman, a professor of immunology at Imperial College London, told The Finanical Times the new variant should actually strengthen the case "for all to get vaccinated as soon as possible," explaining that the mutations won't be able to fool the neutralizing antibodies produced by the shot. Francois Balloux, director of the University College London Genetics Institute, concurred, saying "it's not a strain that should be able to escape protection provided by immunization from the current vaccines or prior infection."
That said, Trevor Bedford, a virologist who has kept a close watch on the virus throughout the pandemic, does think there should eventually be a process in place to update the vaccines so they can keep up with more significant mutations, much like there is for the flu vaccine. He is not, however, worried about that affecting the 2021 vaccine rollout, while also clarifying that potential future drops in vaccine efficacy will likely be "modest." Read more at The Financial Times and check out Bedford's Twitter thread below. Tim O'Donnell
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The Pam Bondi and Dan Bongino schism threatens Trump's DOJ
In the Spotlight Two MAGA partisans find themselves on either end of a growing scandal over Jeffrey Epstein and his ties to White House officials
-
8 ways Trump's bill will change your taxes
The Explainer The 'big beautiful bill' was recently signed into law. Here's what it might mean for your wallet.
-
One great cookbook: 'The Cook You Want to Be'
The Week Recommends And the way you want to eat — now
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths